Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/3809
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrachi P Parvatikar, Sumangala Patil, Joy Hoskeri, Sandeep Swargam, Raghvendra Kulkarni, Kusal K Das.-
dc.date.accessioned2021-07-10T10:29:53Z-
dc.date.available2021-07-10T10:29:53Z-
dc.date.issued2021-
dc.identifier.citationPrachi P Parvatikar, Sumangala Patil, Joy Hoskeri, Sandeep Swargam, Raghvendra Kulkarni, Kusal K Das. Screening, development of transglutaminase-2 inhibitors and its derivative as anti-lung cancer agent by insilico and in vitro approaches. Current Computer-Aided Drug Design. https://doi.org/10.2174/1573409917666210322120350. 2021.en_US
dc.identifier.issn15734099-
dc.identifier.urihttp://hdl.handle.net/123456789/3809-
dc.language.isoenen_US
dc.titleScreening, development of transglutaminase-2 inhibitors and its derivative as anti-lung cancer agent by insilico and in vitro approaches.en_US
dc.typeArticleen_US
Appears in Collections:Faculty of Pharmacology

Files in This Item:
File Description SizeFormat 
32_2021.html89.16 kBHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.